Associate Professor of Obstetrics and Gynecology, University Colorado
Obstetrics & Gynecology
Dr. Kian Behbakht, MD
|
|
Give Review
Kian Behbakht practices Obstetrics & Gynecology. He went to The Ohio State University College of Medicine. He over the years received 3 awards: "Regional Top Doctor", "CMS Meaningful Use Stage 1 Certification" and "Fellow (FACOG)". Kian Behbakht is a published MD. He published 46 publications, including: 'Allelotype analysis of uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q.' He is registered with Medicare and accepts Medicare payments.
Publications
- Progestin treatment decreases CD133+ Cancer stem cell populations in endometrial Cancer.
- Association Between Preoperative Chemotherapy and Postoperative Complications in Patients Undergoing Surgery for Ovarian Cancer.
- Comparative Surgical Outcomes for Endometrial Cancer Patients 65 Years Old or Older Staged With Robotics or Laparotomy.
- Randomized Phase III Trial of Gemcitabine Plus Docetaxel Plus Bevacizumab or Placebo As First-Line Treatment for Metastatic Uterine Leiomyosarcoma: An NRG Oncology/Gyn...
- Association between gelatin-thrombin matrix use and abscesses in women undergoing Pelvic surgery.
- Anti-ma2 paraneoplastic encephalitis in association with recurrent Cervical cancer.
- A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated With PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial o...
- Outcomes of women with atypical glandular cells on preoperative cytology and endometrial Cancer.
- Gynecologic Biopsy for Molecular Profiling: A Review for the Interventional Radiologist.
- On the TRAIL to successful Cancer therapy? Predicting and counteracting resistance against TRAIL-based therapeutics.
- Risk-Reducing Salpingectomy as Preventative Strategy for Pelvic Serous Cancer.
- Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian Cancer cells.
- Specificity and prognostic validation of a polyclonal antibody to detect Six1 homeoprotein in ovarian Cancer.
- Retrospective analysis of survival improvement by molecular biomarker-based personalized chemotherapy for recurrent ovarian Cancer.
- Adenosarcoma in a patient with vaginal Endometriosis.
- Gardnerella vaginalis isolated from patients With bacterial vaginosis and from patients With healthy vaginal ecosystems.
- Characteristics and survival of Cervical cancer patients managed at adjacent urban public and university medical centers.
- Allelotype analysis of Uterine leiomyoma: localization of a potential tumor suppressor gene to a 4-cM region of chromosome 7q.
- Clinical characteristics of clear cell Carcinoma of the ovary.
- BRCA1, BRCA2, and hereditary nonpolyposis colorectal Cancer gene mutations in an unselected ovarian Cancer population: relationship to family history and implications ...
- Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian Carcinoma.
- Racial differences in survival from gynecologic Cancer.
- Adenovirus-mediated gene therapy of ovarian Cancer in a mouse model.
- Clinical and pathological features of ovarian Cancer in women with germ-line mutations of BRCA1.
- A bleomycin/ifosfamide/cisplatin regimen exhibits poor activity against persistent or recurrent squamous gynecologic Cancers.
- Mutations of the BRCA2 gene in ovarian Carcinomas.
- All-trans-retinoic acid inhibits the proliferation of cell lines derived from human Cervical neoplasia.
- Prognostic indicators of survival in advanced endometrial Cancer.
- Expression and mutation analysis of the p53 gene in uterine papillary serous Carcinoma.
- Mutation analysis of the BRCA1 gene in ovarian Cancers.
- Surgical risk score predicts suboptimal debulking or a major perioperative complication in patients with advanced epithelial ovarian, Fallopian tube, or primary perito...
- Phase II trial of the mTOR inhibitor, temsirolimus and evaluation of circulating tumor cells and tumor biomarkers in persistent and recurrent epithelial Ovarian and pr...
- Lobular endocervical glandular hyperplasia with extensive mucinous differentiation of endometrium and endometrial mucinous adenoCarcinoma in situ: a case report and re...
- Distinct TRAIL resistance mechanisms can be overcome by proteasome inhibition but not generally by synergizing agents.
- TRAIL receptor signaling regulation of chemosensitivity in vivo but not in vitro.
- Total pelvic exenteration With a split-thickness skin graft neovagina, continent orthotopic neobladder and rectal reanastomosis, resulting in no external ostomies and ...
- A phase 2, randomized, double-blind, placebo-controlled trial of clinical activity and safety of subcutaneous A6 in women with Asymptomatic CA125 progression after fir...
- Protein kinase C inhibitor Gö6976 augments caffeine-induced reversal of chemoresistance to cis-diamminedichloroplatinum-II (CDDP) in a human ovarian Cancer model.
- TRAIL receptor-targeted therapeutics: resistance mechanisms and strategies to avoid them.
- Photoprotective effects of bucillamine against UV-induced damage in an SKH-1 hairless mouse model.
- Six1 overexpression in ovarian Carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival.
- Biphasic tumors of the female genital tract.
- Social and cultural barriers to Papanicolaou test screening in an urban population.
- Histologic findings from the cervix among older women with abnormal Cervical cytology.
- Role of the vaginal microbiological ecosystem and cytokine profile in the promotion of Cervical dysplasia: a case-control study.
Schools
Ohio State University College Of Medicine
Rush University Medical Center Program
University Of Pennsylvania Program
Procedures Preformed
- Abdominal Hysterectomy With Robotic Assistance
- Colposcopy
- Destruction or Excision of Lesion of Cervix (incl. LEEP)
- Destruction or Excision of Vaginal Lesions
- View All
Conditions Treated
- Asymptomatic Post-Menopausal Status
- Carcinoma in Situ
- Cervical Cancer
- Cervical Polyps
- View All
Doctors Specialties
- Gynecologic Oncology
- Obstetrics
- Gynecology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Pathway X Bronze Direct CACA IN HIX
- Anthem Blue Cross Blue Shield PPO
- Assurant Health
- Blue Card PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Golden Rule
- Humana
- Mail Handlers Benefit Plan (MHBP)
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Regional Top Doctor
- CMS Meaningful Use Stage 1 Certification
- Fellow (FACOG)
Education
-
Rush University Medical Center -
The Ohio State University College of Medicine
Hospital
-
University of Colorado Hospital -
Denver Health
Drug Facts
| NPI NUMBER | 1003919960 | |
| NPPES Provider LastName | BEHBAKHT | |
| NPPES Provider FirstName | KIAN | |
| NPPES Provider ZIPCode | 800452545 | |
| NPPES Provider State | CO | |
| Specialty Description | Obstetrics/Gynecology | |
| Total Claim Count | 129.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1003919960 |
| Last Name Of The Provider | BEHBAKHT |
| First Name Of The Provider | KIAN |
| View All |
Similar Doctors
|
Dr. Monique Spillman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Laurice J. Iskander, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Susan A. Davidson, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Saketh R. Guntupalli, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Ruben J. Alvero, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Deborah K. Hoerter |